SCHEMBL21863293

SCHEMBL21863293

Ic1ncn(-c2ccccn2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.47
POLB P06746 1/20 0.46
HDAC8 Q9BY41 2/20 0.41
ALKBH2 Q6NS38 1/20 0.40
EGLN1 Q9GZT9 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HTT P42858 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PLD1 Q13393 1/20 0.39
EP300 Q09472 1/20 0.38
KAT2B Q92831 1/20 0.38
RAB9A P51151 1/20 0.37
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11079233 0.78 GRM5 (0.49) GRM5POLBALKBH2EGLN1SMN1; SMN2
SCHEMBL5204921 0.78 GRM5 (0.46) GRM5POLBALKBH2EGLN1SMN1; SMN2
SCHEMBL13045111 0.78 SMN1; SMN2 (0.47) GRM5POLBALKBH2EGLN1SMN1; SMN2
SCHEMBL2550402 0.78 GRM5 (0.46) GRM5POLBALKBH2EGLN1SMN1; SMN2
SCHEMBL7152205 0.76 GRM5 (0.54) GRM5POLBALKBH2EGLN1SMN1; SMN2
SCHEMBL6450076 0.76 GRM5 (0.65) GRM5POLBALKBH2EGLN1SMN1; SMN2
SCHEMBL19119928 0.74 GRM5 (0.46) GRM5POLBHDAC8ALKBH2EGLN1
SCHEMBL28543136 0.74 GRM5 (0.49) GRM5POLBALKBH2EGLN1SMN1; SMN2
SCHEMBL28589923 0.74 GRM5 (0.43) GRM5POLBALKBH2EGLN1SMN1; SMN2
SCHEMBL21848975 0.74 GRM5 (0.43) GRM5POLBALKBH2EGLN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020065614-A1 MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-04-02 WO disclosed